BridgeMD
New treatment option for Alcohol Use Disorder
Official title Motivational Interviews Post Hospitalisation on Maintaining AbstiNence for 1 Year après le Sevrage en Alcool
ClinicalTrials.gov ID: NCT06618755
What this study is testing
- What it's testing
- The aim of this clinical study is to evaluate the efficacy of reinforced inpatient aftercare versus usual care on the percentage of days of abstinence during the first year following withdrawal in adults with alcohol use disorders undergoing inpatient withdrawal. The hypothesis is that reinforced post-withdrawal follow-up, of the motivational interview type, during the first 4 months following hospitalisation, in addition to the usual care, would allow : Increase the percentage of days of abstinence in the year following withdrawal.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- With alcohol use disorders defined by at least 2 DSM-V criteria for at least 12 months).
- Being treated for withdrawal in hospital.
- With a goal of complete abstinence.
- With a means of communication (telephone).
You likely can't join if
- Lack of understanding (written and spoken) of the French language.
- Breach of HC withdrawal contract, following failure to comply with the rules of the addictology service and somatic complications of addiction.
- Eviction from the department, discharge against medical advice during hospitalisation for withdrawal.
- Proven cognitive problems compromising understanding of the implications of the study and the proposed follow-up. proposed follow-up.
- Serious decompensated somatic pathology.
- Non-membership or non-beneficiaries of a national health insurance scheme.
See the full eligibility criteria
- With alcohol use disorders defined by at least 2 DSM-V criteria for at least 12 months).
- Being treated for withdrawal in hospital.
- With a goal of complete abstinence.
- With a means of communication (telephone).
- Lack of understanding (written and spoken) of the French language.
- Breach of HC withdrawal contract, following failure to comply with the rules of the addictology service and somatic complications of addiction.
- Eviction from the department, discharge against medical advice during hospitalisation for withdrawal.
- Proven cognitive problems compromising understanding of the implications of the study and the proposed follow-up. proposed follow-up.
- Serious decompensated somatic pathology.
- Non-membership or non-beneficiaries of a national health insurance scheme.
- Person protected by law, under guardianship or curatorship.
- Not having signed free and informed consent to participate in the research.
- Simultaneous participation in another clinical trial.
The study team makes the final eligibility decision.
Where it's taking place
- Montpellier, France
Compensation & support
A stipend or compensation may be offered.
Compensation likely.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Montpellier, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.